Compare OBIO & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OBIO | EVTL |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | 454 |
| Industry | Medicinal Chemicals and Botanical Products | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 235.6M |
| IPO Year | 2020 | N/A |
| Metric | OBIO | EVTL |
|---|---|---|
| Price | $3.90 | $1.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $14.25 | $12.70 |
| AVG Volume (30 Days) | 201.3K | ★ 2.2M |
| Earning Date | 05-11-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,482,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.43 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1169.22 | N/A |
| 52 Week Low | $2.20 | $1.20 |
| 52 Week High | $5.42 | $7.35 |
| Indicator | OBIO | EVTL |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 32.38 |
| Support Level | $3.77 | N/A |
| Resistance Level | $4.18 | $1.79 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 68.52 | 11.11 |
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.